Matches in Wikidata for { <http://www.wikidata.org/entity/Q64623368> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q64623368 description "clinical trial" @default.
- Q64623368 description "ensayu clínicu" @default.
- Q64623368 description "klinisch onderzoek" @default.
- Q64623368 description "клінічне випробування" @default.
- Q64623368 name "Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Subjects With HER2 Positive Early Breast Cancer" @default.
- Q64623368 type Item @default.
- Q64623368 label "Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Subjects With HER2 Positive Early Breast Cancer" @default.
- Q64623368 prefLabel "Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Subjects With HER2 Positive Early Breast Cancer" @default.
- Q64623368 P1132 Q64623368-866A5554-D5C5-4E44-B181-AC2FEB01DE54 @default.
- Q64623368 P1476 Q64623368-22B757FE-7BBC-437D-B463-F5FDDBEE9D48 @default.
- Q64623368 P17 Q64623368-06BC86E3-DD30-4D53-95F3-37284D66BCFD @default.
- Q64623368 P17 Q64623368-09F65D90-FF7D-4FCC-B46B-9C4E57DB0FB6 @default.
- Q64623368 P17 Q64623368-0AF7F653-1FED-4A43-9115-13BB7C4A4B99 @default.
- Q64623368 P17 Q64623368-2FE139B6-3027-46DF-97FA-711EEC074C6E @default.
- Q64623368 P17 Q64623368-31269B83-2930-4E17-8103-46BE10B6A574 @default.
- Q64623368 P17 Q64623368-37C6069E-2835-4EF3-BDDE-3A3C6192AE3C @default.
- Q64623368 P17 Q64623368-55703D1B-FBDC-4F11-8F33-C5BBF769039E @default.
- Q64623368 P17 Q64623368-5906D8D2-E6EA-40DB-9529-131E21300608 @default.
- Q64623368 P17 Q64623368-5C227115-420C-4B5D-BD4F-08B8487D9FBE @default.
- Q64623368 P17 Q64623368-62B7778A-C80E-4227-9E13-8B738B278C71 @default.
- Q64623368 P17 Q64623368-73CB9F60-7413-4327-8282-D6AE5C592B02 @default.
- Q64623368 P17 Q64623368-745889ED-CA91-44C6-9FCE-07BEA4EB1124 @default.
- Q64623368 P17 Q64623368-7FDC0040-F79A-47E5-B38A-AA8DC16E0B76 @default.
- Q64623368 P17 Q64623368-9B438CEA-9388-40FF-86F1-D2B5EC0222C1 @default.
- Q64623368 P17 Q64623368-9DA704AE-7981-4862-B370-962575303E75 @default.
- Q64623368 P17 Q64623368-E02511BD-73FE-4AB3-B856-4CF2F3D9AB1E @default.
- Q64623368 P17 Q64623368-EB685FA3-2A4C-482A-B68F-3FD677B36A22 @default.
- Q64623368 P1813 Q64623368-AD07DD9D-3C4C-41D5-B6A0-CE89DACA1512 @default.
- Q64623368 P2899 Q64623368-EFA78262-D819-4E31-B5A5-9BDA8A2653E1 @default.
- Q64623368 P3098 Q64623368-DE324FEE-7ECD-455F-A15C-FF5F6BD242BD @default.
- Q64623368 P31 Q64623368-7194A9A0-3A6B-4516-9751-5A2C09428291 @default.
- Q64623368 P4844 Q64623368-A0DD0BBC-9A2F-49AC-9963-A1D2DA85A4C3 @default.
- Q64623368 P4844 Q64623368-ADA057B9-ED26-424F-BAC6-F4845FA004DD @default.
- Q64623368 P580 Q64623368-C0CBB1C5-670E-4B0C-99B8-60263C6ACEBD @default.
- Q64623368 P582 Q64623368-645E0EC6-41BC-4C39-9E34-2F172391B8B9 @default.
- Q64623368 P6099 Q64623368-FB5F353F-53A1-47F5-920E-6F1551894D04 @default.
- Q64623368 P8363 Q64623368-9B0B0C01-1128-48DE-9372-2972C08B17C8 @default.
- Q64623368 P1132 "+827" @default.
- Q64623368 P1476 "A Randomized, Double-Blind, Phase 3 Study Evaluating the Efficacy and Safety of ABP 980 Compared With Trastuzumab in Subjects With HER2 Positive Early Breast Cancer" @default.
- Q64623368 P17 Q145 @default.
- Q64623368 P17 Q155 @default.
- Q64623368 P17 Q16 @default.
- Q64623368 P17 Q183 @default.
- Q64623368 P17 Q184 @default.
- Q64623368 P17 Q212 @default.
- Q64623368 P17 Q218 @default.
- Q64623368 P17 Q219 @default.
- Q64623368 P17 Q258 @default.
- Q64623368 P17 Q28 @default.
- Q64623368 P17 Q29 @default.
- Q64623368 P17 Q298 @default.
- Q64623368 P17 Q36 @default.
- Q64623368 P17 Q38 @default.
- Q64623368 P17 Q403 @default.
- Q64623368 P17 Q41 @default.
- Q64623368 P17 Q96 @default.
- Q64623368 P1813 "Lilac" @default.
- Q64623368 P2899 "+18" @default.
- Q64623368 P3098 "NCT01901146" @default.
- Q64623368 P31 Q30612 @default.
- Q64623368 P4844 Q408524 @default.
- Q64623368 P4844 Q423762 @default.
- Q64623368 P580 "2013-04-29T00:00:00Z" @default.
- Q64623368 P582 "2016-05-05T00:00:00Z" @default.
- Q64623368 P6099 Q42824827 @default.
- Q64623368 P8363 Q78089383 @default.